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ABSTRACT
Bone marrow-derived dendritic cells (BM-DCs) are generated from bone marrow (BM) cells 
cultured with granulocyte macrophage-colony stimulating factor (GM-CSF) for a week. In 
this study we investigated the effect of duration on the BM culture with GM-CSF. Within 
several months, the cells in the BM culture gradually expressed homogeneous levels of CD11c 
and major histocompatibility complex II on surface, and they became unable to stimulate 
allogeneic naïve T cells in mixed lymphocyte reaction (MLR). In addition, when the BM 
culture were sustained for 32 wk or longer, the BM cells acquired ability to suppress the 
proliferation of allogeneic T cells in MLR as well as the response of ovalbumin-specific OT-I 
transgenic T cells in antigen-dependent manner. We found that, except for programmed 
death-ligand 1, most cell surface molecules were expressed lower in the BM cells cultured 
with GM-CSF for the extended duration. These results indicate that BM cells in the extended 
culture with GM-CSF undergo 2 distinct steps of functional change; first, they lose the 
immunostimulatory capacity; and next, they gain the immunosuppressive ability.
Keywords: Bone marrow; Dendritic cells; Granulocyte-macrophage colony-stimulating factor; 
Lymphocyte culture test, mixed; Immunosuppression
INTROCUDTION
Antigen presenting cells (APCs) such as dendritic cells (DCs) and macrophages are important 
players mediating innate and adaptive immunity. Particularly, DCs are the most potent 
professional APCs that stimulate and induce the proliferation of naïve T cells (1-3). In the 
bone marrow (BM), common DC progenitor (CDP) cells and monocytes are derived from 
monocyte and DC progenitor cells (4). CDP cells give rise to classical DCs and plasmacytoid 
DCs in FMS-like tyrosine kinase 3 ligand-dependent manner during the steady state (5). 
On the other hand, monocytes are converted into monocyte-derived DCs in the culture 
with granulocyte macrophage-colony stimulating factor (GM-CSF) and IL-4, or during the 
inflammation caused by microbial infection (6).
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DCs are efficiently generated from BM following in vitro culture with GM-CSF for a 
week, which has been a standard way to produce BM-derived DCs (BM-DCs) for various 
experiments (3,7,8). Although culturing BM-DCs is a less cumbersome method to prepare 
DCs in quantity than isolating in situ DCs from animal organs and tissues, it still requires 
freshly isolated BM cells (BMCs) and laborious cell culture procedures. To provide 
better convenient tools for experimenting with DCs, there have been efforts to establish 
immortalized cell-lines that retain the characteristics and functions of BM-DCs (9,10). 
DC-like cell-lines, such as DC2.4, were generated from BM cells cultured with GM-CSF, 
immortalized with J2 retrovirus encoding viral myc and raf oncogenes, and selected for 
dendritic morphology (9). Initially, DC2.4 cell-line was described to present antigens 
efficiently (9) and many researchers have used DC2.4 cell-line instead of BM-DCs for various 
experiments in vitro and in vivo (11-15). A later study, however, revealed that DC2.4 cell-line 
could become poor in presenting antigens to the responding T cells (16).
In this study, we continuously propagated BM cells with GM-CSF for extended periods, i.e., up to 
a year or longer, and evaluated their ability to stimulate T cells. In several months of culture with 
GM-CSF, BM cells expressed homogeneous levels of major histocompatibility complex (MHC) 
class II (MHC II) and CD11c on surface but were unable to induce the proliferation of allogeneic 
T cells in mixed lymphocyte reaction (MLR). Then, after further extension of the culture period, 
we also found that those cells in the BM culture became immunosuppressive to prevent the 
responses of both allogeneic T cells and ovalbumin (OVA)-specific OT-I transgenic T cells.
MATERIALS AND METHODS
Animals
Mice were maintained and bred in specific pathogen-free facilities of the Department of 
Laboratory Animal Resources at the Yonsei University College of Medicine. OT-1 transgenic 
(Tg) mice carrying anti-OVA T cell receptors (TCRs) and congenic CD45.1 (B6.SJL-
PtprcaPepcb/BoyJ) C57BL/6 mouse were purchased from Jackson Laboratory (Bar Harbor, ME, 
USA) and bred in house. C57BL/6 and BALB/c mice were purchased from Jackson Laboratory 
and Orient Bio (Seongnam, Korea). Animal care and experiments were carried out according 
to the guidelines and protocols set by the Institutional Animal Care and Use Committee 
(IACUC) of the Yonsei University College of Medicine.
Cells, antibodies, and reagents
Cells were cultured in DMC7 medium (17) composed of DMEM containing L-glutamine, high 
glucose, and pyruvate (catalog number SH30243; HyClone, Logan, UT, USA) and 7% fetal calf 
serum (HyClone) supplemented with 1× solutions of non-essential amino acids (HyClone) 
and antibiotic-antimycotic (HyClone).
Following conjugated anti-mouse antibodies were purchased from BioLegend (San Diego, 
CA, USA): APC-Cy7-conjugated anti-I-A/I-E (anti-MHC II, clone: M5/114.15.2), and anti-
CD45.2 (clone: 104); PE-conjugated anti-CD11c (clone: N418), anti-CD4 (clone: GK1.5), 
anti-CD8a (clone: 53-5.8), and anti-programmed death ligand 2 (PD-L2; clone: TY25); PerCP-
Cy5.5-conjugated anti-CD11c (clone: N418), anti-CD8a (clone: 53-5.8), and anti-Vα2 (clone: 
B20.1); PE-Cy7-conjugated anti-TCR β chain (clone: H57-597), and anti-CD11b (clone: M1/70); 
BV421-conjugated anti-programmed death-ligand 1 (PD-L1; clone: 10F.9G2); Alexa Fluor 
647-conjugated anti-IDO1 (clone: 2E2/IDO1); biotin-conjugated anti-CD19 (clone: 6D5), 
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anti-CD49b (pan-NK cells, clone: DX5), and anti-I-A/I-E (clone: M5/114.15.2). Cell Trace™ 
carboxyfluorescein succinimidyl ester (CFSE) cell proliferation kit (Thermo Fisher Scientific, 
Waltham, MA, USA) and LIVE/DEAD® fixable dead cell stain kit (Thermo Fisher Scientific) 
were purchased and used according to the manufacturer's instructions. OVA was purchased 
from Sigma-Aldrich (St. Louis, MO, USA).
BM culture
Whole BM cell suspension was prepared from femurs and tibias of C57BL/6 mice as described 
(7,18). Then, the BM cells were counted and cultured in 24-well tissue culture plates at 1×106 
cells per well with DMC7 medium containing GM-CSF as described previously (17). For 
short-term (up to 7 days) cultures of BM cells, a half of medium in each well was carefully 
removed and replenished with new GM-CSF-containing DMC7 medium on every 2 or 3 days. 
For long-term cultures of BM cells, the extended culture was sustained by removing non-
adherent or loosely-attached BM cells periodically, i.e., every 1 or 2 wk, and maintaining only 
the remaining adherent BM cells in tissue culture plates. Non-adherent or loosely-attached 
BM cells were discarded or harvested for analysis by mild pipetting and replenished with new 
GM-CSF-containing DMC7 medium.
Allogeneic MLR
Cell suspensions, prepared by grinding up spleens and lymph nodes from BALB/c mice with 
frosted glasses and cell strainers (BD Biosciences, San Jose, CA, USA), were incubated with 
the mixture of biotin-conjugated monoclonal antibodies against CD19, CD49b, and MHC II. 
After washing with isolation buffer (PBS containing 2% fetal bovine serum and 2 mM EDTA), 
antibody-reactive cells were removed using biotin-binding magnetic beads (Dynabeads; 
Thermo Fisher Scientific) according to the manufacturer's instruction. The enriched T cells 
(1×107 cells in 1 ml) were mixed with 1 μl of 0.5 mM CFSE solution and incubated for 10 min 
at 37°C, followed by quench with DMC7 medium and washed with PBS. Then, for MLR, 5×104 
of CFSE-labeled T cells were co-cultured with the graded doses of non-adherent or loosely-
attached cells from the different BM cultures of C57BL/6 mice in 96-well tissue culture plates. 
After 4 to 5 days, the proliferation of T cells was measured by CFSE dilution detected with 
FACSVerse™ flowcytometer (BD Biosciences).
Suppressor cell-mediated T cell suppression assay was performed in conjunction with 
allogeneic MLR. In brief, 1W-BMCs, i.e., C57BL/6 BM cells cultured with GM-CSF for 1 wk, 
were mixed with graded doses of control syngeneic splenocytes or suppressor cells to be 
tested, and further subjected to co-incubation with CFSE-labeled allogeneic T cells from 
BALB/c mice and analysis as described above.
Assay of suppressor cell activity on anti-OVA T cells
Cells in the BM culture were pre-treated with medium containing 100 μg/ml of soluble OVA 
for 1 h at 37°C. Then, the OVA-laden BMCs were washed twice with cold DMEM and co-
cultured with anti-OVA OT-I TCR Tg T cells as described below. Splenic OT-I T cells were 
enriched by excluding CD4+, CD19+, CD49b+, and MHC II+ splenocytes using appropriate 
biotinylated antibodies and Dynabeads (Thermo Fisher Scientific), labeled with CFSE, and 
added to round bottom 96-well plates at 105/well. Then, OT-I T cells were co-cultured with 
OVA-laden 1W-BMCs plus graded doses of control syngeneic splenocytes or suppressor cells 
for 3 days. Proliferation of live OT-I T cells was evaluated by CFSE dilution and staining with 
the appropriate mixture of dead cell staining dye and fluorochrome-conjugated anti-CD45.2, 
anti-TCR β, anti-Vα2, and anti-CD8.
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Stimulation of cells with lipopolysaccharide (LPS)
Cells in the BM cultured for 1 wk or longer than a year were stimulated side by side with 
LPS (catalog number L2630; Sigma-Aldrich) at 100 μg/ml for 18 h at 37°C. Then, cells were 
harvested, washed twice with PBS, stained for various surface molecules, and subjected to 
flow cytometric analysis.
Statistical analysis
Experiments with multiplicate samples were analyzed for statistical comparisons between 
different groups using unpaired Student's t-test using Prism6 (GraphPad Software, La Jolla, 
CA, USA). Statistical significance is denoted by the p-values equal or below 0.05, 0.01, and 
0.001. Data were plotted for graphs with Prism6.
RESULTS AND DISCUSSION
In our previous study (19), we found that BM-DCs isolated from 3- or 4-wk old BM cultures 
were much less efficient to stimulate T cells than BM-DCs from 1-wk old BM culture. 
To follow up on our previous finding that BM-DCs lose their capacity to induce the 
proliferation of allogeneic T cells in MLR after the extended culture with GM-CSF (19), we 
set out to examine the culture of BM cells from C57BL/6 mice for lengthy periods. To sustain 
and examine the extended culture of BM cells, non-adherent or loosely-attached cells were 
removed from tissue culture plates every 1 or 2 wk and only the remaining adherent cells 
were maintained in culture medium containing GM-CSF. Then we discovered that new 
non-adherent or loosely-attached cells were continually produced from the BM culture of 
adherent cells, and analyzed those non-adherent or loosely-attached cells periodically for 
longer than a year.
Every 4 wk or so, we compared the capacity to stimulate allogeneic T cells from BALB/c 
mice in MLR between the 1-wk cultured BM cells and the long-term cultured BM cells. 
Similarly to our previous study (19), non-adherent or loosely-attached cells in the 4-wk old 
BM culture were found less efficient to stimulate allogeneic T cells than those in the 1-wk 
old BM culture (Fig. 1A). When cultured for 8 wk, BM cells in the culture (i.e., non-adherent 
or loosely-attached cells in the BM culture) became almost completely unable to stimulate 
the proliferation of allogeneic T cells in MLR (Fig. 1B). The loss of capability to stimulate 
allogeneic T cells in MLR was continuously observed from BM cells in the long-term culture 
throughout the extended periods of their culture with GM-CSF (Supplementary Fig. 1).
Non-adherent or loosely-attached BM cells in the 1-wk culture with GM-CSF are composed 
of heterogeneous populations including a large majority of CD11c+CD11b+MHC IIint/lo 
macrophages and a relative smaller number of CD11c+CD11b+MHC IIhi DCs (19-21). Both 
of the BM cells cultured with GM-CSF for 1 wk as well as for 4 wk exhibited heterogeneous 
populations with regard to their surface level of MHC II (Fig. 2A), whereas those cultured for 
20 wk or longer became a relatively homogeneous population in terms of expressing surface 
MHC II (Fig. 2B).
Although cells from the long-term cultures of BM with GM-CSF were unable to stimulate 
allogeneic T cells in MLR (Supplementary Fig. 1), those cells expressed both MHC I and MHC 
II on surface throughout the extended culture periods (Figs. 2 and 3). Then, we examined 
whether BM cells from the long-term culture possessed the ability to suppress T cell responses. 
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Figure 1. Cells from the extended cultures of BM with GM-CSF lose their capacity to stimulate allogeneic T cells. BM cells isolated from C57BL/6 mouse are cultured with 
GM-CSF, and harvested in 4-wk intervals. The 5×104 CFSE-labeled allogeneic T cells from BALB/c mouse are co-cultured with 1.7×104 BM cells derived respectively from  
(A) 4-, and (B) 8-wk old cultures in comparison with the 1-wk old culture. After 4 days, CFSElow T cells are analyzed by a flow cytometer and counted. Representative 
data are shown from at least 2 independent experiments in quadruplicate. Error bars indicate mean ± standard error of the mean across quadruplicate samples. 
**p≤0.01, ***p≤0.001.
As shown in Fig. 4, cells from the BM cultured for 32 wk or longer were found to effectively 
suppress the proliferation of allogeneic T cells in MLR stimulated by the 1-wk cultured BM cells. 
This suppressor activity of the long-term cultured BM cells was maintained throughout our 
examinations which lasted well over a year (Fig. 4 and Supplementary Fig. 1). Then, we further 
investigated whether those BM cells in the long-term culture exert their suppressor activity in 
antigen-dependent manner. The long-term cultured BM cells were treated with/without OVA 
before adding into the co-culture with the OVA-loaded 1-wk cultured BM cells and anti-OVA 
OT-I TCR transgenic T cells. Only the long-term cultured BM cells laden with OVA were able to 
suppress the response of OVA-specific OT-I T cells (Fig. 5).
Our results indicate that BM cells cultured with GM-CSF undergo 2 distinct steps of functional 
change; the BM cells cultured for 8 wk or longer lose immunostimulatory capacity; and those 
cultured for 32 wk or longer gain immunosuppressive ability. To evaluate whether these changes 
are due to the altered expression of surface molecules, we compared the levels of various co-
stimulatory and surface molecules between the 1-wk cultured BM cells and the 70-wk cultured 
BM cells. The expression of CD25, CD40, CD80, CD86, PD-L2, and MHC I were significantly 
diminished while the expression of PD-L1 was augmented on the surface of the 70-wk cultured 
BM cells (Fig. 3). We also tested whether the stimulation with LPS, a TLR4 agonist, could 
change the function of the long-term cultured BM cells. As shown in Fig. 6, LPS treatment 
increased the immunostimulatory activity of the 1-wk cultured BM cells but exhibited no such 
effect on the long-term cultured BM cells.
It is currently not yet clear that the expressional change of these co-stimulatory molecules 
during extended culture is responsible for those BM cells to lose immunostimulatory 
capacity or to gain immunosuppressive ability. The new features acquired by the BM cells in 
the extended cultures are apparently shared by the typical phenotypes of tolerogenic DCs, 
including the increased level of PD-L1 and the decreased levels of CD40, CD80, CD86 (22). 
Further investigation is needed to define the mechanisms that cause the functional changes 
of BM cells in the course of the extended culture with GM-CSF.
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Figure 2. Long-term cultured BM cells retain homogeneous levels of CD11c and MHC II. BM cells cultured with 
GM-CSF for 1 wk versus (A) 4 wk or (B) 57 wk are compared for their MHC II and CD11c expression. Representative 
data are shown from at least 2 independent experiments.
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Figure 3. The expression of surface molecules is evaluated on BM cells in the extended cultures with GM-CSF. BM cells in the 1-wk and 70-wk old cultures are 
stained side by side with antibodies against the indicated molecules. (A) In the 1-wk old BM culture, CD11c+MHC IIhi cells are gated as DCs in red tetragon and 
CD11c+MHC IIint cells are gated as macrophages in purple tetragon. The whole BM cells in the 70-wk old culture are gated for analysis. (B) Histograms illustrate 
the staining of a respective antibody (open red line) versus an isotype control (area filled with gray). The expression of each molecule is detected on cell 
surface but IDO-1 detected intracellularly. Mean fluorescent index is denoted in each histogram. Representative data are shown from at least 2 independent 
experiments.
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Figure 4. Cells from the extended cultures of BM with GM-CSF are suppressive to MLR. (A) BM cells cultured for 1 wk (1W-BMC) were mixed with either control 
syngeneic splenocytes or BM cells cultured long-term (LT-BMC) for 16 or 32 wk and co-cultured with 5×104 CFSE-labeled allogeneic T cells isolated from BALB/c 
mice. After 4 days, CFSElow allogeneic T cells are assessed. Representative flow cytograms are shown from 2 independent experiments in quadruplicate. (B) The 
suppressor cell activity of BM cells in extended cultures at different time points is assessed as in (A). Assays are performed at the ratios of 1(+):1(+):3(+) and 
1(+):3(+++):3(+) for 1W-BMC:LT-BMC/Splenocyte:Allogeneic T cell. The number of CFSElow T cells were counted and plotted in graphs. Data are generated from 2 
independent experiments in quadruplicate. Error bars indicate mean ± standard error of the mean across quadruplicate samples. 
*p≤0.05, **p≤0.01, ***p≤0.001. (continued to the next page)
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Figure 4. (Continued) Cells from the extended cultures of BM with GM-CSF are suppressive to MLR. (A) BM cells cultured for 1 wk (1W-BMC) were mixed with 
either control syngeneic splenocytes or BM cells cultured long-term (LT-BMC) for 16 or 32 wk and co-cultured with 5×104 CFSE-labeled allogeneic T cells 
isolated from BALB/c mice. After 4 days, CFSElow allogeneic T cells are assessed. Representative flow cytograms are shown from 2 independent experiments in 
quadruplicate. (B) The suppressor cell activity of BM cells in extended cultures at different time points is assessed as in (A). Assays are performed at the ratios of 
1(+):1(+):3(+) and 1(+):3(+++):3(+) for 1W-BMC:LT-BMC/Splenocyte:Allogeneic T cell. The number of CFSElow T cells were counted and plotted in graphs. Data are 
generated from 2 independent experiments in quadruplicate. Error bars indicate mean ± standard error of the mean across quadruplicate samples. 
*p≤0.05, **p≤0.01, ***p≤0.001.
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Figure 5. Cells from the extended culture of BM with GM-CSF are suppressive to the proliferation of OT-I T cells in antigen-dependent manner. (A) BM cells 
cultured for 1 wk (1W-BMC), 60-wk old BM cells cultured long-term (LT-BMC), and control syngeneic splenocytes are pre-treated with OVA (100 μg/ml), mixed as 
indicated, co-cultured with 105 CFSE-labeled OT-I T cells for 3 days, and analyzed for the number CFSElow OT-I T cells. (B) The suppressor cell activity is assessed 
as in (A) except that 62-wk old LT-BMC and control syngeneic splenocytes are not pre-treated with OVA. Assays are performed at the ratios of 1(+):1(+):100(+), 
1(+):3(++):100(+), and 1(+):10(+++):100(+) for 1W-BMC:LT-BMC/Splenocyte:OT-I T cell. The number of CFSElow T cells were counted and plotted in graphs. Data are 
generated from 2 independent experiments in triplicate. Error bars indicate mean ± standard error of the mean across triplicate samples. 
NS, not significant. 
*p≤0.05, **p≤0.01, ***p≤0.001.
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SUPPLEMENTARY MATERIAL
Supplementary Figure 1
BM cells isolated from C57BL/6 mouse are cultured with GM-CSF, and harvested in 4-week 
intervals.
Click here to view
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